Anshika Jain
The innate immune system provides an immediate, broad response to invading organisms, while the adaptive immune system develops highly specific responses and can retain long-lasting memory of previous encounters. When the same pathogen appears again, memory B cells and T cells can respond more rapidly and effectively than they did during the initial exposure.
This traditional division has become more complicated with the emergence of a concept known as trained immunity. Research over the past decade has shown that certain innate immune cells can undergo long-lasting functional changes after exposure to microorganisms, vaccines, or other inflammatory signals. When these cells encounter a later stimulus, they may respond differently from cells that have not previously been exposed. Scientists refer to this phenomenon as trained immunity, or innate immune memory.
Trained immunity does not mean that innate immune cells remember pathogens in exactly the same way as adaptive immune cells. Instead, previous exposure can leave behind changes in cellular metabolism, chromatin accessibility, gene regulation, and the behaviour of immune-cell progenitors. These changes can make subsequent innate responses stronger, faster, or otherwise altered.
The discovery has created a new area of immunology because it suggests that the innate immune system is more adaptable than previously believed. It also raises important questions. How is this biological memory stored? How long can it last? Can it protect against unrelated infections? Could it contribute to chronic inflammation? And could scientists deliberately induce or suppress trained immunity for therapeutic purposes?
The Traditional View of Innate and Adaptive Immunity
The human immune system is commonly divided into innate and adaptive components. Innate immunity provides the body’s first line of defence. Cells such as monocytes, macrophages, neutrophils, natural killer cells, and dendritic cells recognise broad molecular patterns associated with pathogens or tissue damage.
Adaptive immunity operates differently. B cells and T cells use highly specific receptors to recognise particular antigens. Following an immune response, populations of memory B and T cells can remain in the body and respond more rapidly when the same or a related antigen is encountered again.
This distinction led to the long-standing idea that immunological memory was primarily an adaptive immune phenomenon. Innate immune cells were generally viewed as short-lived responders that returned to their baseline state after an infection or inflammatory event.
Trained immunity challenges the simplicity of this model. Research indicates that certain innate immune cells can undergo persistent functional reprogramming after an initial stimulus. The subsequent response may be enhanced even when the second stimulus is different from the first.
The term “memory” is therefore used carefully. Trained immunity is not equivalent to classical antigen-specific adaptive memory. It represents a form of biological adaptation in which previous exposure changes how innate immune cells respond to later challenges.
What Exactly Is Trained Immunity?
Trained immunity can be described as a long-lasting change in the functional state of innate immune cells following an initial stimulus. After the initial exposure, the cells may undergo metabolic and epigenetic changes that influence how genes involved in immune responses are expressed during subsequent stimulation.
Monocytes and macrophages have been among the best-studied cells in this field. Natural killer cells and other innate immune populations can also display memory-like characteristics under certain circumstances. Research has further revealed that the effects of training may extend beyond mature circulating immune cells to hematopoietic stem and progenitor cells in the bone marrow.
This distinction is important because many innate immune cells have relatively limited lifespans. If trained responses persist longer than individual cells survive, researchers need to understand how the information is maintained. Evidence increasingly points toward changes in hematopoietic progenitors, which can influence the characteristics of newly generated immune cells.
Trained immunity is therefore not simply a cell becoming “stronger” after an infection. It is a complex biological programme involving cellular metabolism, gene regulation, chromatin organisation, and the production of new immune cells.
How the Biological Memory Is Stored
One of the most important discoveries in trained immunity research is the role of epigenetic regulation. Epigenetics refers to changes in gene activity that do not require changes to the underlying DNA sequence.
When innate immune cells encounter certain stimuli, signalling pathways can modify chromatin and alter the accessibility of genes involved in inflammatory and antimicrobial responses. Histone modifications, changes in chromatin structure, and other regulatory mechanisms can make particular genes more readily available for transcription when a later stimulus occurs.
This does not mean that the DNA sequence itself has been rewritten. Instead, the cell’s regulatory system has been altered in a way that can influence future behaviour.
Researchers have identified specific histone modifications associated with trained immunity, including changes around genes involved in inflammatory responses. These modifications can create a more permissive chromatin environment, allowing trained cells to produce certain immune mediators more efficiently when they are stimulated again.
Epigenetic regulation therefore provides one explanation for how an innate immune cell can retain information about a previous biological experience without possessing the antigen-specific receptors characteristic of adaptive memory.
Metabolism Is Part of the Memory
Epigenetics is only one part of the trained immunity process. Cellular metabolism is also deeply involved.
Immune cells change their metabolic behaviour when they become activated. Research on trained immunity has shown that certain training stimuli can produce persistent metabolic reprogramming, including increased reliance on glycolytic pathways and alterations in mitochondrial and intermediary metabolism.
These metabolic changes are not simply consequences of immune activation. Metabolites generated by cellular metabolic pathways can themselves influence epigenetic enzymes and chromatin regulation. This creates a connection between metabolism and gene expression.
For example, changes in pathways regulated by mTOR and hypoxia-inducible factor 1-alpha can contribute to metabolic reprogramming during trained immunity. Metabolic intermediates can then influence enzymes responsible for modifying histones and other components of chromatin.
The result is a feedback relationship between metabolism and epigenetic regulation. The cell’s energy-processing system can influence which genes are accessible, while changes in gene expression can alter how the cell uses energy.
This connection helps explain why trained immunity is increasingly studied as an immunometabolic phenomenon rather than purely as an immunological one.
BCG Vaccine and the Discovery of Trained Immunity
One of the most important examples associated with trained immunity is the Bacillus Calmette-Guérin vaccine, commonly known as BCG. BCG is a live attenuated vaccine developed against tuberculosis.
Researchers observed that BCG vaccination could produce immune effects extending beyond protection against tuberculosis. Experimental and clinical research has investigated whether BCG can produce enhanced innate responses to unrelated microorganisms, a phenomenon sometimes described as heterologous or nonspecific protection.
Research has linked these effects to changes in monocytes, macrophages, natural killer cells, and their progenitor populations. BCG can activate innate immune pathways and induce epigenetic and metabolic changes that influence subsequent responses.
The BCG story was particularly important because it provided evidence that a vaccine could potentially influence innate immune behaviour beyond the pathogen it was designed to target.
However, the broader effects of BCG vaccination vary according to population, timing, previous exposure, vaccination history, and study design. Therefore, trained immunity should not be interpreted as evidence that BCG universally provides broad protection against every infection.
Instead, BCG has served as an important experimental model for understanding how innate immune memory may work.
Beta-Glucan and Other Training Stimuli
BCG is not the only stimulus capable of inducing trained immunity. Research has also examined microbial components such as beta-glucans, which are polysaccharides found in the cell walls of fungi and some other organisms.
Experimental studies have shown that beta-glucan exposure can reprogramme innate immune cells and alter their responses to later challenges. Other microbial molecules and inflammatory signals have also been investigated as potential inducers.
The important point is that trained immunity is not restricted to one microorganism or one receptor pathway. Different stimuli can activate different molecular programmes, and the resulting trained state may differ depending on the biological context.
Researchers have also begun investigating endogenous danger signals, sometimes called damage-associated molecular patterns, as potential inducers of trained immunity. Recent research suggests that noninfectious signals associated with tissue injury, metabolic disturbances, and chronic disease may contribute to persistent innate immune reprogramming.
This finding expands the concept beyond infectious disease and raises important questions about the relationship between trained immunity and chronic inflammation.
Can Trained Immunity Protect Against Unrelated Infections?
One of the most interesting features of trained immunity is its potential to provide protection against pathogens that are different from the organism that originally induced the trained state.
Unlike adaptive immune memory, which is generally highly specific to particular antigens, trained immunity can alter broad innate responses. A trained macrophage may exhibit enhanced antimicrobial functions when exposed to a later stimulus that does not share the same antigen as the original training stimulus.
Studies involving BCG have provided evidence for such heterologous effects, while experimental work with other training stimuli has explored similar mechanisms.
This broad responsiveness could be biologically useful because the innate immune system frequently encounters pathogens it has never seen before. A memory-like system that enhances general antimicrobial functions could potentially improve early defence without requiring previous exposure to every individual pathogen.
At the same time, stronger innate responses are not automatically beneficial. Excessive inflammatory activity can damage tissues, which means trained immunity must be understood as a regulated biological programme rather than a simple enhancement mechanism.
Trained Immunity Can Also Become Harmful
The same mechanisms that may improve host defence can potentially contribute to disease when they become excessive or persist inappropriately.
Inflammatory diseases often involve prolonged activation of innate immune pathways. If metabolic and epigenetic reprogramming creates an exaggerated inflammatory response, trained immunity could contribute to a cycle in which subsequent stimuli generate disproportionately strong inflammation.
Recent research has investigated connections between trained immunity and conditions involving chronic inflammation, including cardiovascular disease, rheumatoid arthritis, periodontitis, kidney disease, and other immune-mediated disorders.
This creates an important scientific balance. Researchers are investigating how trained immunity might be induced when stronger host defence is desirable while also exploring whether inappropriate trained responses could be reduced in chronic inflammatory conditions.
The objective is therefore not simply to maximise trained immunity. It is to understand how the process can be regulated according to biological context.
Trained Immunity and Bone Marrow Stem Cells
One of the most significant developments in the field is the discovery that trained immunity can involve hematopoietic stem and progenitor cells in the bone marrow.
These cells generate different types of blood cells throughout life. If an infection, vaccine, or inflammatory stimulus changes the functional programme of these progenitors, the effects could continue even after the original stimulus has disappeared.
Recent research describes this phenomenon as “central trained immunity.” Epigenetic and metabolic changes in hematopoietic progenitors can influence the production and functional characteristics of their descendants.
This provides a potential explanation for how an innate immune memory-like state can persist longer than the lifespan of individual monocytes or macrophages.
It also changes the way scientists think about immune memory. Rather than storing biological information exclusively inside mature immune cells, the immune system may retain some forms of information within the processes that generate future immune cells.
Trained Immunity and Vaccines
The discovery of trained immunity has opened new questions about vaccine design. Traditional vaccines are generally developed to generate antigen-specific adaptive immune responses, particularly memory B and T cells.
Researchers are now exploring whether vaccines can also be designed to influence innate immune memory. The possibility is particularly interesting for pathogens that mutate rapidly or for situations in which broad early immune protection could be valuable.
Recent research has investigated trained immunity in childhood vaccination and has considered whether live vaccines such as BCG, measles-containing vaccines, and oral polio vaccine may produce broader immune effects beyond their target pathogens.
However, these effects require careful interpretation. Vaccine responses involve both innate and adaptive immunity, and observed protection cannot automatically be attributed to trained immunity alone.
Future vaccine research may nevertheless examine innate immune programming alongside conventional antibody and T-cell responses.
Could Trained Immunity Become a Therapeutic Target?
The ability to induce or suppress trained immunity raises the possibility of therapeutic applications.
If researchers can identify reliable molecular pathways that create beneficial trained responses, they may eventually be able to develop interventions that enhance innate host defence. Such strategies could potentially be relevant to infections, cancer, or conditions involving impaired immune responses.
Conversely, if trained immunity contributes to persistent inflammatory disease, therapies designed to interrupt specific metabolic or epigenetic pathways could potentially reduce pathological innate immune activation.
Research has already identified therapeutic targeting of trained immunity as an emerging area, although many proposed applications remain experimental.
The challenge will be achieving sufficient precision. Innate immune pathways are interconnected with normal host defence, so suppressing them too broadly could create unwanted susceptibility to infection or impair tissue repair.
The Role of Epigenetic and Metabolic Research
Understanding trained immunity requires researchers to connect several levels of biology. Genetic information provides the underlying blueprint, but epigenetic regulation determines which genes are accessible and active. Metabolism supplies energy and produces molecules that can influence gene regulation. Cellular signalling connects environmental stimuli with these internal processes.
This makes trained immunity an excellent example of how modern immunology increasingly overlaps with other disciplines.
Epigenomics can identify changes in chromatin and histone modifications. Metabolomics can identify changes in cellular metabolites. Single-cell sequencing can reveal how individual immune-cell populations respond differently to training stimuli. Computational approaches can help integrate these datasets.
The combination of these technologies may eventually allow scientists to predict which stimuli create specific forms of trained immunity and which biological consequences are likely to follow.
What Remains Unknown?
Despite major advances, many questions remain unresolved. Researchers still need to understand precisely how long trained immunity persists in different human populations, why individuals respond differently to the same training stimulus, and how environmental factors influence the process.
The relationship between trained immunity and adaptive immunity also requires further investigation. The two systems do not operate independently, and vaccination or infection can activate both simultaneously.
Another major question concerns specificity. Trained immunity is often described as nonspecific, but different stimuli can produce distinct cellular programmes. Understanding how broad or context-dependent these responses are will be important for developing safe interventions.
Researchers must also determine when an enhanced innate response is beneficial and when it becomes harmful. A stronger inflammatory response may improve pathogen clearance in one situation while increasing tissue damage in another.
The Future of Innate Immune Memory Research
The concept of trained immunity has changed the scientific understanding of what the innate immune system can do. It suggests that innate immune cells are capable of adapting their future behaviour according to previous biological experiences.
Future research is likely to investigate trained immunity at increasingly precise levels, from individual immune cells and epigenetic marks to bone marrow progenitors and whole-body inflammatory networks. Scientists may also investigate how diet, metabolism, infections, vaccines, aging, and chronic diseases influence innate immune memory.
The field could eventually contribute to new approaches in vaccine design, infectious disease prevention, cancer immunology, and inflammatory disease treatment. However, these applications require rigorous clinical evidence. Much of the mechanistic understanding has emerged from experimental systems, and translating those findings into reliable human therapies remains an important challenge.
Conclusion
Trained immunity represents one of the most interesting developments in modern immunology because it challenges the traditional assumption that biological memory belongs exclusively to the adaptive immune system.
Research shows that innate immune cells can undergo persistent functional changes after exposure to certain microorganisms, vaccines, and inflammatory signals. These changes involve epigenetic and metabolic reprogramming and can influence how cells respond to later challenges. In some circumstances, the effects may also involve hematopoietic stem and progenitor cells, allowing altered immune behaviour to persist through the generation of new immune cells.
The potential advantages are significant. Trained immunity may contribute to broader protection against unrelated infections and could offer new possibilities for vaccine development and immunotherapy. At the same time, persistent or excessive innate immune training may contribute to chronic inflammation and disease.
The emerging picture is therefore more nuanced than simply saying that the innate immune system has “memory.” Trained immunity is a form of biological adaptation in which previous experiences can alter the future behaviour of innate immune cells through interconnected metabolic, epigenetic, and cellular mechanisms.
As researchers continue to understand these mechanisms, the concept could reshape the study of immune memory. The immune system may not be divided into a rapidly responding innate system and a memory-forming adaptive system as neatly as once believed. Instead, both arms may possess different forms of biological learning, with innate and adaptive memory working together to shape how the body responds to its changing environment.